Safety and Immunogenicity Study of Aleph Inactivated Split Influenza Vaccine

NCT01758185 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
3308
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Beijing Center for Disease Control and Prevention